News
For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...
Best Life on MSN34m
Weight-Loss Drugs Could Slash Cancer Risk by 41%—Here’s Who BenefitsParticipants in a new study who used GLP-1 drugs had a much lower cancer risk than those who had bariatric surgery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback